Mouse mammary tumour virus has been reported to be an aetiological agent of most mammary gland tumours, some lymphomas and renal carcinomas in mice (for review see Salmons & Giinzburg, 1987) . Although it is a very suitable model of carcinogenesis in mice no such role for MMTV-like species has been demonstrated for human breast cancer.
Antigens immunologically related to MMTV proteins have been found in human breast cancer tissues as well as in various mammary cancer cell lines. Retrovirus-like particles were purified from culture media of human mammary cell line T47D. Antigen immunologically related to MMTV gp52 was detected in viral preparations and also in a soluble form in culture media (Keydar et al., 1984) . Reverse transcriptase activity associated with retrovirus-like particles has recently been reported in monocytes from breast cancer patients (AlSumidaie et al., 1988) . There exists a vast literature concerning the presence of antibodies of MMTV proteins in sera of breast cancer patients (see e.g. Witkin et al., 1980; Day et al., 1981; Tomana et al., 1981; Holder & Wells, 1983; Zotter et al., 1983; Dion et al., 1987) . However, the specificity of the antibodies used in these studies has been controversial. These studies frequently used enzyme-linked immunoadsorbent assays (ELISA) and cellular immunofluorescence (CIF). Such techniques cannot accurately distinguish specific and nonspecific reactions of sera. Some authors believe that most reactiveness of human sera against viral proteins could be accounted for by heterophilic antibodies that bind the carbohydrate moieties of viral glycoproteins (Barbacid et al., 1980; Snyder & Fleissner, 1980) . Nevertheless, human sera have been reported to react with core MMTV proteins using radioimmunoprecipitation (RIP) and ELISA with purified MMTV proteins (Zotter et al., 1983; Dion et al., 1987) . In addition, human-human hybridoma cell lines derived from lymph nodes of breast cancer have been reported which produce monoclonal antibodies against MMTV proteins (Shoenfeld et al., 1987) . Molecular cloning techniques have revealed the presence of numerous nucleotide sequences related to the MMTV genome in human DNA (Callahan et al., 1982; Deen & Sweet, 1986; Ono et al., 1986; Franklin et al., 1988) . All human endogenous retroviruses studied so far are defective or incomplete although some contain functional LTR and even long open reading frames. Their transcripts have been detected in various cancer cell lines and also in normal human placenta. Enhanced transcription upon the steroid treatment was shown in the T47D breast cancer cell line and for the transcripts of the NMWV 4 family (Ono et al., 1987; Franklin et al., 1988) . Source of the viruses GR/N cells grown in RPMI 1640 medium containing 5% fetal calf serum produced MMTV upon dexamethasone treatment. Bovine leukaemia virus (BLV) was produced by FLK cells. Avian myeloblastosis virus (AMV) was purified from plasma of infected chickens. Murine leukaemia virus strain Rauscher (Ra-MuLV) was a gift of Dr Gruber from NCI, Bethesda. All retroviruses were purified by isopycnic sucrose gradient centrifugation.
Electrophoresis and protein hlotting Viral proteins were separated in sodium dodecyl sulphate polyacrylamide gradient (5 -22%) slab gel (SDS-PAGE) (Laemmli, 1970) . Electrophoretic transfer to nitrocellulose sheets (0.45 gm, Schleicher & Schuell) was performed according to Bittner et al., (1980) using 0.04 M sodium phosphate, pH 7.0 as a transfer buffer. Transferred proteins were visualised by amidoblack 10 B (Syu & Kahan, 1987) or by colloidal silver (Kovarik et al., 1987) for higher sensitivity.
Immunodetection
The nitrocellulose sheet was cut into 0.5 cm wide strips. Each strip carried a large quantity of MMTV proteins (approximately 100 tg) to increase the sensitivity of the immunodetection. Strips were incubated for 2 h at 25°C in BLOTTO (5% non-fat dry milk in 50 mM Tris-HCl, pH 8.2, 2 mM CaCI2, 80 mM NaCl, 0.2% Triton X-100, 10-5% merthiolate and 0.01% Antifoam) to block non-specific antibody binding. All human test sera were diluted 1: 100 in BLOTTO. Hyperimune sera were used in dilutions from 1:1000 to 1:200. Strips were incubated with diluted sera overnight at 4°C. After the incubation, strips were washed 3 x with TEN buffer (50 mM Tris-HCI, pH 7.4, 5 mM EDTA, 0.15 M NaCl, 0.05% Tween 20). After 30 min of washing 1251 Protein-A was added to final activity of 5.0 x 106 c.p.m. ml1' of BLOTTO and incubated for 60 min at 25°C. The strips were then washed several times with TEN, dried, mounted and autoradiographed (13-max films, Amersham). In the case of mouse or goat antibodies, the appropriate horse-radish peroxidase-labelled anti-immunoglobulin (DAKO) was used and the colour was developed by diaminobenzidine /H202 reaction.
Radiolabelling of Protein-A Protein-A was labelled by Na'251 (Amersham) by the chloramine T method (Greenwood et al., 1963 Figure 1 Immunoblotting patterns in serum samples reacting with MMTV proteins. Lane 1: amidoblack staining of transferred MMTV proteins. Lane 2: serum from patient with acute myelogenous leukemia (1:100 dilution). Lane 3: serum from patient with malignant melanoma (1:100 dilution). Lanes 4,5: sera from healthy controls (1:100 dilution). Lane 6: rabbit anti-MMTV serum (1:1,000 dilution). Lane 7: preimmune serum (1:100 dilution). Lane 8: goat anti-MPMV serum (1:200 dilution). tects actin as the upper band in the 42 kDa region; in contrast the reaction of human sera is with the lower band. Furthermore when a less pure MMTV preparation was used as the antigen, a broad band was observed when anti-actin monoclonal antibody was used (Figure 2b, lane 2) . Human sera, however, reacted with a protein migrating as a sharp band. The less pure isolate of MMTV was obtained from cell culture media with a high content of cellular debris. The purity of the virus is highly dependent on the state of the producing cell culture. However, even the most pure retroviral preparations always contain cellular proteins as contaminants and actin is a well known example.
The described reactions of human sera with cellular contaminants of the virus show the advantages of immunoblot or RIP over ELISA and CIF for screening of specific antibodies to viral proteins. . Interestingly the incidence of the reactions with these two antigens is relatively high in healthy controls (about 12% for p30 and 9% for p14). We found that the titre remained unchanged during a 2-year period in one healthy blood donor. We suggest that the reactions to p30 and p14 are not connected with any pathological conditions and that natural antibodies spontaneously appearing in sera without any known antigenic stimulus may be responsible for these reactivities. Reactions with major core protein p27 and envelope glycoprotein gp52 predominated in sera of cancer patients. Sera of p27 and gp52 specificities reacted with no other protein in these experiments.
It was reported that antibodies to MMTV antigens can be detected in sera of more than 20% of breast cancer patients using ELISA or CIF techniques (Witkin et al., 1980; Day et al., 1981; Tomana et al., 1981; Holder & Wells, 1983) . Our results show that the incidence of specific antibodies to MMTV proteins is much lower and no increased frequency is observed in breast cancer sera. In contrast, human sera especially those of breast cancer patients detected a cellular contaminant of the virus in the 42 kDa region. We suggest that the previously published increased levels of antibodies to MMTV in breast cancer sera are the result of reactions with cellular contaminants of the virus rather than with viral proteins themselves.
The humoral response might be directed to exogenous agents or to self antigens. In our opinion the reactions of human sera to MMTV proteins are probably of autoimmune origin. Exposure to an MMTV-like agent is improbable because (a) low frequencies of reactions to p27 and gp52 (about 2% for p27 and 3% for gp52 of all cancer patients sera tested and (b) we did not find any sera containing both types of antibodies i.e. to p27 and gp52. The autoimmune response might be directed against the product of activated endogenous retrovirus related to MMTV or against some cellular protein that shares partial sequence homology with viral proteins. The latter situation has been described for autoimmune reactions of sera from patients with mixed connective tissue disease recognising the 70 kDa protein of U,snRNP immunologically cross-reactive with p30 MuLV (Query & Keene, 1987) . The conclusions can be summarised as follows: (I) specific antibodies recognising MMTV proteins sporadically appear in human sera. (2) Most frequent reactivities are to transframe protein p30 and ribonucleoprotein p14. These reactions occur in sera of cancer patients and healthy controls. (3) Specific reactions to major core protein p27 and envelope glycoprotein gp52 were observed predominantly in sera of cancer patients but their prevalence is low. (4) Reactions with 42 kDa cellular contaminant of the virus occur more frequently than specific reactions to MMTV proteins and they might be responsible for false positivities in ELISA and CIF assays. (5) No direct correlation between the incidence of malignant disease and the presence of specific antibodies to MMTV proteins can be found due to their low incidence. Nevertheless, their sporadic occurrence may help further search for antigens circumstantially expressed during carcinogenesis.
